Cargando…
369. Using Hybrid Models and Blockchain Technology as a Means to Develop a Novel Propensity Score for Candidemia and Invasive Candidiasis
BACKGROUND: Early initiation of empiric antifungal therapy has been shown to decrease morbidity and mortality among patients with candidemia/invasive candidiasis (C/IC). However, the initiation of appropriate antifungal therapy is frequently delayed due to the severe limitations in early diagnosis....
Autores principales: | Rao, Arni Sr Srinivasa, Vazquez, Jose, Ostrosky-Zeichner, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254950/ http://dx.doi.org/10.1093/ofid/ofy210.380 |
Ejemplares similares
-
1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study
por: Thompson, George R, et al.
Publicado: (2018) -
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009) -
Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?
por: Ostrosky-Zeichner, Luis
Publicado: (2011) -
2037. Utilization of the T2 Magnetic Resonance in the Early Detection of Invasive Candidiasis
por: Patel, Sonal, et al.
Publicado: (2018) -
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial
por: Thompson, George R, et al.
Publicado: (2020)